When a trial’s safety profile changes, the logistics that depend on that profile change too. This piece follows how a change in monitoring burden affects site operations, participant communications, and PRO collection.
Sponsors and sites increasingly need social determinants of health (SDOH) to understand barriers to enrollment and retention. This piece frames the operational questions about how you collect SDOH, who you reach by phone or SMS, and how those answers feed site workflows.
IRT, IVRS, IWRS, IXRS and RTSM all name one kind of trial system: it assigns treatment and tracks study drug. Here is what each term means and why it matters.
How research teams choose PROMIS domains, forms and collection modes for clinical studies, and what to plan for scoring, scheduling and data quality checks.
What site coordinators, pharmacists, depot staff and study managers actually do in an IRT system each day, and how IRT connects to EDC and CTMS systems.
The three jobs IRT does in a clinical trial: enrolling and randomizing participants, keeping study drug where it is needed, and protecting the study blind.
Long-acting injectable regimens change the work from daily pills to scheduled clinic encounters. That shift exposes gaps in participant scheduling, safety screening, and multilingual follow-up. This article explains the operational failure points sponsors and sites should check before a large rollout.
A QA checklist for ePRO audit trails under 21 CFR Part 11: who, what, when, before and after values, frozen survey versions, immutable responses, and more.
A practical guide to dosing diaries by phone and text: what self-report can and cannot tell you, how to design check-ins, and how to pair diaries with other measures.
Learn the difference between IVRS for randomization and patient-facing IVR for diaries and check-ins, and how a phone-based ePRO call flow works in a study.
eCOA vs ePRO explained, plus how provisioned devices, BYOD, IVR, and web compare, and why many studies add phone and text for participants who skip the app.
Designing a clinical trial as a hub-and-spoke network is an operational choice, not just a recruitment strategy. The model widens geographic and demographic reach, but it also multiplies the number of independent timelines you must monitor: each participant has their own day-0, dosing windows, and…